Data protection Impressum

R&D

Geneva-based Neurosoft Bioelectronics has set a new benchmark in neurotechnology with its high-resolution, stretchable brain interface for epilepsy monitoring. The EPFL spin-off successfully tested its device on two human patients, paving the way for broader clinical applications.

Neurosoft Bioelectronics advances brain interface technology for epilepsy and tinnitus

5 March 2025

CSEM has unveiled Switzerland’s first-ever dry room, a state-of-the-art facility designed to accelerate the commercialization of next-generation batteries.

CSEM inaugurates Switzerland’s first dry room for next-generation batteries

3 March 2025

Biotech company CELLnTEC is playing a key role in the NEOLIVER project, a European-Swiss initiative developing the world’s first autologous bioprinted liver for clinical use. The project, co-funded by the EU and the Swiss government, aims to address the global organ donor shortage through innovative bioprinting technologies.

Bern-based CELLnTEC joins NEOLIVER project to develop bioprinted liver constructs

10 February 2025

The Swiss Institute of Bioinformatics has inaugurated the Centre for Pathogen Bioinformatics in Bern, a state-of-the-art facility dedicated to strengthening genomic surveillance of infectious diseases.

The Centre for Pathogen Bioinformatics was inaugurated in Bern

4 February 2025

CSEM, in collaboration with Thales Alenia Space and Lisi Aerospace Additive Manufacturing, has created an innovative 3D-printed pipe segment for advanced thermal management systems in satellites.

CSEM develops a 3D-printed thermal control system for satellites

22 January 2025

Vaud cleantech Composite Recycling has reached a major milestone with the installation of its first industrial-scale recycling plant in Nantes, France. The move sets the stage for the Ecublens-based company to expand its operations and meet the growing global demand for sustainable composite waste solutions.

Composite Recycling delivers its first industrial-scale recycling unit

15 January 2025

Vandria, a Lausanne-based biotech pioneer in mitochondrial therapeutics, has dosed the first participants in a Phase 1 clinical trial for its lead compound, VNA-318, marking a critical step toward addressing neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Vandria begins clinical trials for Alzheimer’s drug VNA-318

7 January 2025

Siegfried, a prominent Swiss Contract Development and Manufacturing Organization (CDMO), has unveiled its new global Research and Development (R&D) center at its site in Evionnaz, in the canton of Valais.

Siegfried has inaugurated its global R&D center in Evionnaz

4 December 2024

Nutrazur, a French company specializing in essential oil powders and natural health products, is setting up at the PhytoArk in the canton of Valais, attracted by the excellence of the local ecosystem.

Nutrazur establishes its first Swiss subsidiary at PhytoArk in Conthey

26 November 2024

Empa’s newly inaugurated DroneHub on the NEST campus aims to redefine the role of drones and robotics in addressing global environmental and infrastructure challenges.

Empa inaugurates a pioneering facility for sustainability robotics

25 November 2024

1 2 3 4 5 … 12